The T‐Body Approach: Towards Cancer Immuno‐Gene Therapy

This chapter contains sections titled: Background CRs with Antitumor Specificity Optimizing the CR Design Anticancer Specificities of CRs Pre‐Clinical Experimental Models Clinical Trials Conclusions and Perspectives Background CRs with Antitumor Specificity Optimizing the CR Design Anticancer Specificities of CRs Pre‐Clinical Experimental Models Clinical Trials Optimizing the CR Design Anticancer Specificities of CRs Pre‐Clinical Experimental Models Clinical Trials Conclusions and Perspectives